Cleared Traditional

K091539 - IQ 200 URINE ANALIZER BODY FLUIDS MODULE

K091539 is an FDA 510(k) clearance for IQ 200 URINE ANALIZER BODY FLUIDS MODULE, manufactured by Iris Diagnostics. The device is a Class 2 Hematology device with product code GKL cleared through the Traditional 510(k) pathway after a 462-day FDA review.

K091539 · Iris Diagnostics · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2010
Decision
462d
Days
Class 2
Risk

K091539 is an FDA 510(k) clearance for the IQ 200 URINE ANALIZER BODY FLUIDS MODULE. Classified as Counter, Cell, Automated (particle Counter) (product code GKL), Class II - Special Controls.

Submitted by Iris Diagnostics (Chatsworth, US). The FDA issued a Cleared decision on August 31, 2010 after a review of 462 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5200 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Hematology submissions.

View all Iris Diagnostics devices

FDA 510(k) Submission Details - K091539

510(k) Number K091539 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 26, 2009
Decision Date August 31, 2010
Days to Decision 462 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
349d slower than avg
Panel avg: 113d · This submission: 462d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKL Device Classification - Class 2, Special Controls

Product Code GKL Counter, Cell, Automated (particle Counter)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKL Counter, Cell, Automated (particle Counter)

All 99
Devices cleared under the same product code (GKL) and FDA review panel - the closest regulatory comparables to K091539.
Glocyte Automated Cell Counter System
K152776 · Advanced Instruments, Inc. · May 2016
HEMOCUE WBC SYSTEM
K071652 · Hemocue AB · Oct 2007
MODIFICATION TO BAYER ADVIA 2120 HEMATOLOGY ANALYZER WITH AUTOSLIDE SYSTEM
K051693 · Bayer Healthcare, LLC · Dec 2005
IQ 200 URINE ANALYZER BODY FLUIDS MODULE
K050235 · Iris International, Inc. · Mar 2005
SYSMEX POCH-100I
K032677 · Sysmex America, Inc. · Feb 2004
ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHOD
K022331 · Bayer Diagnostics Corp. · Sep 2002